Temporary Disabled. :) please Go back Flu prevention - amantadine and oseltamivir www.fgks.org » Address: [go: up one dir, main page] Include Form Remove Scripts Accept Cookies Show Images Show Referer Rotate13 Base64 Strip Meta Strip Title Session Cookies Sign In | Register Home News Get involved About NICE Find guidance NICE Pathways Quality standards Into practice QOF Conditions and diseases Blood and immune system • Cancer • Cardiovascular • Central nervous system • Digestive system • Ear and nose • Endocrine, nutritional and metabolic • Eye • Gynaecology, pregnancy and birth • Infectious diseases • Injuries, accidents and wounds • Mental health and behavioural conditions • Mouth and dental • Musculoskeletal • Respiratory • Skin • Urogenital Public health Accidents and injuries • Alcohol • Behaviour change • Cancer • Cardiovascular disease • Child health • Child social care • Chronic illness • Diabetes • Drugs • Environmental health • Infectious diseases • Maternal health • Mental health • Non-communicable diseases • Obesity and diet • Occupational health • Older people • Physical activity • Sexual health • Smoking and tobacco • Transport • Vaccine preventable diseases • Working with and involving communities Treatments, Procedures and Devices Bones and joint surgery • Cardiovascular surgery • Cardiovascular system drug treatments • Clinical devices • Diagnostic imaging • Diagnostic procedures • Digestive tract and other abdominal organs surgery • Drug treatments • Endocrine system and breast surgery • Eye surgery • Nervous system surgery • Radiotherapy • Screening • Surgical procedures • Therapeutic procedures • Tissue and organ donation • Urogenital surgery Guidance by type Clinical Guidelines • Technology appraisals • Public health guidance • Diagnostics guidance • Interventional procedures guidance • Medical technologies guidance • Cancer service guidance • Quality standards Guidance by date View the guidance by date published About NICE guidance Close Home>About NICE guidance>Guidance by type>Appraisals>Flu prevention - amantadine and oseltamivir TA67 Flu prevention - amantadine and oseltamivir (TA67) (replaced by TA158) Technology appraisals TA67 Issued: September 2003 The clinical effectiveness and cost effectiveness of amantadine and oseltamivir for the prophylaxis of influenza Technology appraisals, TA67 - Issued: September 2003 This guidance has been replaced by TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir Other information How this guidance was produced Background information Review decision Review proposal Assessment report: Influenza A and B This page was last updated: 20 December 2011 Guidance formats Implementation tools and resources None available Patient The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets. Quick Reference Guide The quick reference guide presents recommendations for health professionals NICE Guidance The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies. Full Guidance The published full clinical guidance for specialists with background, evidence, recommendations and methods used. Read more about how we work Close Explore NICE Evidence Search NICE Community About NICE Who we are, What we do, How we work Get involved Current Consultations, Join a working group Scientific Advice Consultancy Advice to pharmaceutical companies Quality Initiatives Clinical commissioning group outcomes indicator set, Quality and Outcomes Framework, NICE fellows and scholars NICE International NICE International Advisory group, International projects NICE accreditation What´s new in accreditation, accreditation decisions Cost saving support NICE Guidance Find Guidance, Clinical Guidelines, Diagnostics, Interventional Procedures, Medical Technologies, Public Health, Quality Standards, Social care, Technology Appraisals NICE Quality Standards Published quality standards, Quality standards in development, Social care quality standards Research and development Research recommendations Search, Latest recommendations Patients and the public Search guidance, Treatment and care, Join a working group Other publications Special reports and HDA publications Social care Support for General Practice Resources for GPs, NICE Commissiong resources Commissioning guides Commissioning guides for Cardiovascular, Central nervous system, Digestive system Putting guidance into practice Benefits, Implementation tools, How to guides, Assessment tools, Help implement NICE Guidance ... Education and learning Education, Strategy, Online tools Shared learning Shared learning implementation guidance Notify NICE New and reviewed Interventional procedures Medicines and prescribing support Evidence summaries: new medicines, Events, Alerts News and press NICE press office, News and features, Press releases, Latest News NICE Events Annual conference, Speaking engagements, Attend a meeting Features and rich media Latest NICE features, Guidance in focus, Podcasts Subscribe for alerts NICE guidance and newsletters Local government Public health briefings for local government Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions Copyright 2013 National Institute for Health and Care Excellence. All rights reserved. Selected, reliable information for health and social care in one place Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions Copyright 2013 National Institute for Health and Care Excellence. All rights reserved. NICE on Twitter @NICEcomms Follow @NICEcomms on Twitter Subscribe to NICE If you are an NHS or public health professional you are eligible to receive NICE guidance by email and post where available. Subscribe to the NICE RSS Feed Stay informed when new content in your area of interest is added to the NICE website Subscribe to NICE news, our free monthly e-newsletter Share NICE Top Guidance Trends Intrapartum care: CG55 Type 2 diabetes (partially updated by CG87): CG66 Hypertension: CG127 Chronic obstructive pulmonary disease (COPD): QS10 Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions Copyright 2013 National Institute for Health and Care Excellence. All rights reserved.
This guidance has been replaced by TA158 Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir
This page was last updated: 20 December 2011
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.
Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions
Copyright 2013 National Institute for Health and Care Excellence. All rights reserved.